StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.41+0.05 (+13.21%)

Close on Nov 17, 2026Market cap $51.44MP/E –Yield –

Milestone Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$559.00K–
Q1 FY2026Mar 31, 2026$238.00K–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–

More Milestone Pharmaceuticals figures

See a number that looks wrong?